GlassScriptPhysician profile
Ahmed F Shoukry
NPI 1104264456
$2,058.69
in general payments reported to CMS, 2019-2025
20 companies · $377 in 2025
The $377 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,222 · 2020: $23.46 · 2023: $87.54 · 2024: $349 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $813.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $813.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $1,162.87 | 2019-2025 | |
| Stryker Corporation | $237.19 | 2020-2025 | Flexband, Augment Injectable, Na |
| Mimedx Group, INC. | $112.48 | 2024-2025 | |
| Depuy Synthes Sales INC. | $80.79 | 2023-2025 | Motoband, Va-Lcp, N/A |
| Amgen INC. | $64.08 | 2025 | Krystexxa |
| Nevro Corp. | $62.07 | 2023-2024 | Senza |
| Paratek Pharmaceuticals, INC. | $49.22 | 2024 | Nuzyra |
| Lifenet Health | $32.99 | 2024-2025 | Theragenesis Wound Matrix |
| Polarityte, INC. | $32.13 | 2019 | |
| Integra Lifesciences Corporation | $29.95 | 2019 | |
| Treace Medical Concepts, INC. | $27.40 | 2023 | |
| Biocomposites INC | $26.98 | 2024 | |
| Biowound Solutions, INC. | $23.74 | 2025 | Bio-Connekt |
| Globus Medical, INC. | $21.64 | 2025 | Senza |
| Convatec INC. | $20.94 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orpyx Medical Technologies US INC. | $18.50 | 2023 | Orpyx Si |
| Arthrosurface Incorporated | $16.83 | 2019 | |
| Smith+Nephew, INC. | $15.24 | 2019 | |
| Orthofix Medical, INC. | $12.94 | 2019 | |
| Kerecis Limited | $10.71 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ahmed Shoukry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.